Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy.
IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier.
[Immune-mediated neuropathies].
Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.
[Sjögren's syndrome (SS), a review of the subject and saliva as a diagnostic method].
A gut (microbiome) feeling about the brain.
Capacity for financial decision making in multiple sclerosis.
Safety, Tolerability, and Immunogenicity of Interferons.
Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in rats.
Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies.
Peculiarities of Neurological Disorders and Study Designs.
[Assessment of severity of neurogenic bowel dysfunction in chronic patients with a simple 1-item questionnaire (PGI-S)].
Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
Astroglial NF-kB contributes to white matter damage and cognitive impairment in a mouse model of vascular dementia.
Opportunities and considerations for visualising neuroimaging data on very large displays.
Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases.
Physical Activity and Its Correlates in Youth with Multiple Sclerosis.
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - YES.
Hippocampal microstructural damage correlates with memory impairment in clinically isolated syndrome suggestive of multiple sclerosis.
Refined clinical scoring in comparative EAE studies does not enhance the chance to observe statistically significant differences.
A Randomized Crossover Trial of Dalfampridine Extended Release for Effect on Ambulatory Activity in People with Multiple Sclerosis.
Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies.
Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration.
Products
Analysis of the neuroregenerative activities of mesenchymal stem cells in functional recovery after rat spinal cord injury.

Pages